LFCM
TCRR

Long Focus Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Long Focus Capital Management’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-566,270
Closed -$849K – 123
2023
Q1 		$849K Buy
+566,270
New +$763K 0.05% 89

Long Focus Capital Management's TCRR Position: Q2 2023 in Review

Long Focus Capital Management sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 566,270 shares — an estimated $849K sold.

Long Focus Capital Management first reported a position in TCRR in Q1 2023 and held it in 1 quarter. The position peaked at $849K in Q1 2023. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

  • Long Focus Capital Management reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Long Focus Capital Management sold 566,270 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $849K.
  • Long Focus Capital Management first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Long Focus Capital Management's TCR2 Therapeutics Inc. Common Stock position peaked at $849K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Long Focus Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.